Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
WORKING PAPERS
April 11, 2024
POLICY PAPERS
April 15, 2024
CGD NOTES
April 08, 2024
WORKING PAPERS
April 04, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
POLICY PAPERS
April 08, 2024
The global locus of undervaccination is increasingly shifting from the poorest countries in the world—which are eligible for support from Gavi, the Vaccine Alliance—to middle-income countries (MICs) that do not qualify for traditional Gavi support. Given these growing challenges, Gavi must rethink i...
CGD NOTES
February 20, 2024
An increasing proportion of official development assistance (ODA) is being dedicated to climate, and climate mitigation in particular. Even were that spending highly effective, and despite reaching about $30 billion in 2020, it is not large enough to finance investment that would significantly slow ...
CGD NOTES
December 06, 2023
Marginal abatement cost curves, which suggest the cheapest approaches to reducing carbon emissions, are out of favor in international climate finance discussions because they are not good tools to use when thinking about systemic and urgent change. On the other hand, international financing studies ...
POLICY PAPERS
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
CGD NOTES
March 09, 2023
High-income countries trying to reach net-zero targets are confronting the fact that existing environmental regulations make it harder to build low-carbon infrastructure. Lobbying groups in the US, for example, are using regulatory tools to block geothermal, solar, and wind facilities. Providing sub...
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
POLICY PAPERS
November 15, 2022
Antimicrobial drugs form the backbone of modern medicine. Yet over time, use of these drugs selects for mutations that survive exposure to those same drugs, driving “antimicrobial resistance,” or AMR. In the absence of sufficient R&D investment for new antimicrobials, deaths from drug-resistant infe...